![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Sustained Virologic Response (SVR) in Prior PegInterferon/Ribavirin (PR) Treatment Failures After Retreatment with Boceprevir (BOC) + PR: PROVIDE Study Interim Results
|
|
|
Reported by Jules Levin
EASL 2012 April 18-22 Barcelona Spain
JP Bronowicki1, M Davis2, S Flamm3, S Gordon4, E Lawitz5, E Yoshida6, J Galati7, V Luketic8, J McCone9, I Jacobson10, P Marcellin11,12, A Muir13, F Poordad14, LD Pedicone15, W Deng15, M Treitel15, J Wahl15, J Vierling16
1University Henri Poincare of Nancy, Vandoeuvre-lès-Nancy, France; 2South Florida Center of Gastroenterology, Wellington, FL; 3Northwestern Feinberg School of Medicine, Chicago, IL; 4Henry Ford Hospital, Detroit, MI; 5Alamo Medical Research, San Antonio, TX; 6University of British Columbia and Vancouver General Hospital, Vancouver, BC, Canada; 7Liver Specialists of Texas, Houston, TX; 8Virginia Commonwealth University School of Medicine, Richmond, VA; 9Mt. Vernon Endoscopy Center, Alexandria, VA; 10Weill Cornell Medical College, New York, NY; 11Universite Denis Diderot-Paris, Paris; 12Hopital Beaujon, Clichy, France; 13Duke University School of Medicine, Durham, NC; 14Cedars-Sinai Medical Center, Los Angeles, CA; 15Merck Sharp & Dohme Corp, Whitehouse Station, NJ; 16Baylor College of Medicine, Houston, TX
International Liver Congress 2012, Abstract 204
47th Annual Meeting of the European Association for the Study of the Liver
Barcelona, Spain
April 20, 2012
![EASL1.gif](../images/042212/042212-6/EASL1.gif)
![EASL2.gif](../images/042212/042212-6/EASL2.gif)
![EASL3.gif](../images/042212/042212-6/EASL3.gif)
![EASL4.gif](../images/042212/042212-6/EASL4.gif)
![EASL5.gif](../images/042212/042212-6/EASL5.gif)
![EASL6.gif](../images/042212/042212-6/EASL6.gif)
![EASL7.gif](../images/042212/042212-6/EASL7.gif)
![EASL8.gif](../images/042212/042212-6/EASL8.gif)
![EASL9.gif](../images/042212/042212-6/EASL9.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|